GSK GSK plc
Stable Earnings Power
B+ 79.4 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
B+ 78
  • 5yr Avg ROIC 14.9%
  • Operating Margin Trend +0.66 pp/yr

Capital Efficiency

Weight: 15%
A+ 100
  • 5yr Avg ROE 39.8%
  • 5yr Share-Count CAGR -10.7%

Growth Quality

Weight: 15%
A- 85
  • 5yr Revenue CAGR 7.2%
  • 5yr EPS CAGR 19.8%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 15%
A 93
  • 5yr FCF Margin 18.9%
  • 5yr FCF/NI Conversion 1.07x

Balance Sheet

Weight: 20%
B 70
  • Net Debt / EBITDA 1.37x
  • Interest Coverage (EBIT/Int) 11.77x
  • Altman Z-Score 1.68

Stability

Weight: 15%
C 54
  • EPS Volatility (σ/μ) 0.72
  • Piotroski F-Score 7
  • Negative-Revenue Years (5) 0/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

2 of 3 gurus held; 1 added; 1 trimmed; 1 full exit.

Holders
2 -1
Avg Δ position
+187.1%
New buys
0
Full exits
1
As of Q1 2026